Medicus Pharma Ltd. (MDCX): Total Assets
$10.06M
As of 2025-12-31
$27.12M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.06M | +78.2% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $5.65M | +198.3% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $1.89M | n/a | 2025-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $10.06M | +78.2% |
| Oragenics Inc (OGEN) | 2025-12-31 | $10.07M | +583.7% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $10.16M | +146.3% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $9.71M | -27.8% |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $9.70M | -4.4% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | $9.62M | -41.5% |
Compare MDCX, OGEN, KRSA, GNPX side by side · Screen every company in Pharmaceutical Preparations ↗